Amos Meltzer
Follow
Get notifications in MyBN when activity occurs.
Amos Meltzer
Non-Executive Director / Paradigm Biopharmaceuticals
Amos Meltzer has over 25 years of experience in international trade, commercialising technologies & life sciences. He has overseen life science research and product development projects as well as clinical trials and the sale & marketing of a pharmaceutical product.
His experience and knowledge is drawn from having worked in law firms (Freehills and K&L Gates) and as in-house counsel and IP director at two Nasdaq-listed companies, as a non-executive director of a biotechnology company, and as vice president of business development and chief executive of ASX-listed biopharmaceutical company Immuron.
His experience and knowledge is drawn from having worked in law firms (Freehills and K&L Gates) and as in-house counsel and IP director at two Nasdaq-listed companies, as a non-executive director of a biotechnology company, and as vice president of business development and chief executive of ASX-listed biopharmaceutical company Immuron.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1692nd | Paradigm Biopharmaceuticals | -65% | -41% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Paradigm Biopharmaceuticals | $6.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEW ROLE: Non-Executive Director, Paradigm Biopharmaceuticals | 22 Dec 2020 |
